| Chr | chr11 |
| start | 65497688 |
| end | 65506516 |
| lncRNA name | MALAT1 |
| entrez id | 378938 |
| hgnc id | HGNC:29665 |
| ensg id | ENSG00000251562 |
| refseq id | NR_002819 |
| methods | qPCR, Western blot, Luciferase reporter assay etc. |
| regulated | up-regulated |
| function description | This study provided evidence that long non-coding RNA MALAT1 was up-regulated in breast cancer tissues and cell lines. MALAT1 promoted cancer cell invasion through inducing epithelial-mesenchymal transition. Interestingly, we revealed there was a reciprocal repression between MALAT1 and miR-204. ZEB2 was identified as a downstream target of miR-204 and MALAT1 exerted its function mainly through the miR-204/ZEB2 axis. Our findings suggested that MALAT1 may serve as a new diagnostic biomarker and therapy target for breast cancer. Patients with higher levels of MALAT1 expression had poorer overall survival than those with lower levels of MALAT1 expression. |
| pubmed id | 28675122 |
| year | 2017 |
| title | MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer. |
| drug | X |
| circulating | X |
| survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China